Table 2.
Variables | All patients N=37 |
Best overall response, n (%) | |
Complete response | 0 |
Partial response | 9 (24.3) |
Stable disease ≥6 weeks | 11 (29.7) |
Progressive disease | 17 (45.9) |
Not evaluable | 0 |
ORR, % (95% CI) | 24.3 (11.8 to 41.2) |
DCR, % (95% CI) | 54.1 (36.9 to 70.5) |
Time to response, months, median (range) | 2.1 (1.8 to 4.1) |
Duration of response, months, median (95% CI) | 4.1 (1.9 to 6.3) |
Progression-free survival, months, median (95% CI) | 4.1 (2.1 to 5.7) |
Overall survival, months, median (95% CI) | 18.9 (10.8 to NR) |
6-month rate (95% CI) | 89.2 (73.7 to 95.8) |
9-month rate (95% CI) | 78.4 (61.4 to 88.5) |
12-month rate (95% CI) | 67.2 (49.4 to 79.9) |
DCR, disease control rate; NR, not reached; ORR, objective response rate.